Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 May;43(4):167-168.
doi: 10.1016/j.acuro.2019.01.002. Epub 2019 Mar 4.

Metastases-free survival rate in non-metastatic castration-resistant prostate cancer: Now living on its own!

[Article in English, Spanish]
Affiliations
Editorial

Metastases-free survival rate in non-metastatic castration-resistant prostate cancer: Now living on its own!

[Article in English, Spanish]
A Juárez-Soto. Actas Urol Esp (Engl Ed). 2019 May.
No abstract available

PubMed Disclaimer

Comment on

  • Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
    Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Clinical Trial.
  • Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.
    Hussain M, Fizazi K, Saad F, Rathenborg P, Shore N, Ferreira U, Ivashchenko P, Demirhan E, Modelska K, Phung D, Krivoshik A, Sternberg CN. Hussain M, et al. N Engl J Med. 2018 Jun 28;378(26):2465-2474. doi: 10.1056/NEJMoa1800536. N Engl J Med. 2018. PMID: 29949494 Free PMC article. Clinical Trial.

Substances

LinkOut - more resources